Malondialdehyde BSA Conjugate

Malondialdehyde (MDA) BSA Conjugate is a well-established marker of lipid peroxidation and oxidative stress in neural tissues. MDA is generated during polyunsaturated fatty acid degradation and forms covalent adducts with proteins, altering their function and immunogenicity. In neurodegenerative diseases such as Alzheimer’s, ALS, and multiple sclerosis, MDA-modified proteins accumulate in affected brain regions, correlating with inflammation, synaptic loss, and neuronal death. MDA also promotes the formation of neoepitopes that trigger autoimmune responses. The MDA-BSA conjugate is used in ELISA and immunohistochemistry to quantify oxidative damage and monitor disease progression, making it a valuable tool in translational neuroscience and biomarker discovery.

Malondialdehyde BSA Conjugate, Malondialdehyde-BSA Conjugate, Malondialdehyde (BSA) Conjugate, MG-BSA, MG-BSA Conjugate, MG-modified BSA, Malondialdehyde-modified BSA, Malondialdehyde Bovine Serum Albumin Conjugate, Malondialdehyde-Bovine Serum Albumin Conjugate, Malondialdehyde (Bovine Serum Albumin) Conjugate, MG-Bovine Serum Albumin, MG-Bovine Serum Albumin Conjugate, MG-modified Bovine Serum Albumin, Malondialdehyde-modified Bovine Serum Albumin, Malondialdehyde-bovine serum albumin